New isoxazolidinyl-based N-alkylethanolamines as new activators of human brain carbonic anhydrases

References

• Supuran CT. Structure and function of carbonic anhydrases. Biochem J. 2016;473(14):2023–2032.
   PubMedGoogle Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opinion on Therapeutic Patents. 2000;10(5):575–600.
   Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT, De Simone G. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev. 2012;112(8):4421–4468.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci. 2021;135(10):1233–1249.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2012;27(6):759–772.
   PubMed Web of Science ®Google Scholar
• Cuffaro D, Nuti E, Rossello A. An overview of carbohydrate-based carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):1906–1922.
   PubMed Web of Science ®Google Scholar
• Masini E, Carta F, Scozzafava A, Supuran CT. Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat. 2013;23(6):705–716.
   PubMed Web of Science ®Google Scholar
• Ciccone L, Cerri C, Nencetti S, Orlandini E. Carbonic anhydrase inhibitors and epilepsy: state of the art and future perspectives. Molecules. 2021;26(21):6380.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat. 2013;23(6):725–735.
   PubMed Web of Science ®Google Scholar
• Poli G, Galati S, Martinelli A, Supuran CT, Tuccinardi T. Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):365–371.
   PubMed Web of Science ®Google Scholar
• Fischer T, Senn N, Riedl R. Design and structural evolution of matrix metalloproteinase inhibitors. Chemistry. 2019;25(34):7960–7980.
   PubMed Web of Science ®Google Scholar
• Nuti E, Cuffaro D, Bernardini E, Camodeca C, Panelli L, Chaves S, Ciccone L, Tepshi L, Vera L, Orlandini E, et al. Development of thioaryl-based matrix metalloproteinase-12 inhibitors with alternative zinc-binding groups: synthesis, potentiometric, NMR, and crystallographic studies. J Med Chem. 2018;61(10):4421–4435.
   PubMed Web of Science ®Google Scholar
• Cuffaro D, Camodeca C, D'Andrea F, Piragine E, Testai L, Calderone V, Orlandini E, Nuti E, Rossello A. Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates. Bioorg Med Chem. 2018;26(22):5804–5815.
   PubMed Web of Science ®Google Scholar
• Nuti E, Rossello A, Cuffaro D, Camodeca C, Van Bael J, van der Maat D, Martens E, Fiten P, Pereira RVS, Ugarte-Berzal E, et al. Bivalent inhibitor with selectivity for trimeric mmp-9 amplifies neutrophil chemotaxis and enables functional studies on mmp-9 proteoforms. Cells. 2020;9(7):1634.
   PubMed Web of Science ®Google Scholar
• Blandina P, Provensi G, Passsani MB, Capasso C, Supuran CT. Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders. J Enzyme Inhib Med Chem. 2020;35(1):1206–1214.
   PubMed Web of Science ®Google Scholar
• Datta R, Shah GN, Rubbelke TS, Waheed A, Rauchman M, Goodman AG, Katze MG, Sly WS. Progressive renal injury from transgenic expression of human carbonic anhydrase IV folding mutants is enhanced by deficiency of p58IPK. Proc Natl Acad Sci USA. 2010;107(14):6448–6452.
   PubMed Web of Science ®Google Scholar
• Shah GN, Bonapace G, Hu PY, Strisciuglio P, Sly WS. Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum Mutat. 2004;24(3):272.
   PubMedGoogle Scholar
• van Karnebeek CD, Sly WS, Ross CJ, Salvarinova R, Yaplito-Lee J, Santra S, Shyr C, Horvath GA, Eydoux P, Lehman AM, et al. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. Am J Hum Genet. 2014;94(3):453–461.
   PubMed Web of Science ®Google Scholar
• Feinstein Y, Yerushalmi B, Loewenthal N, Alkrinawi S, Birk OS, Parvari R, Hershkovitz E. Natural history and clinical manifestations of hyponatremia and hyperchlorhidrosis due to carbonic anhydrase XII deficiency. Horm Res Paediatr. 2014;81(5):336–342.
   PubMed Web of Science ®Google Scholar
• Boyne K, Corey DA, Zhao P, Lu B, Boron WF, Moss FJ, Kelley TJ. Carbonic anhydrase and soluble adenylate cyclase regulation of cystic fibrosis cellular phenotypes. Am J Physiol Lung Cell Mol Physiol. 2022;322(3):L333–L347.
   PubMed Web of Science ®Google Scholar
• Canto de Souza L, Provensi G, Vullo D, Carta F, Scozzafava A, Costa A, Schmidt SD, Passani MB, Supuran CT, Blandina P. Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. Neuropharmacology. 2017; 118(118148):148–156.
   PubMedGoogle Scholar
• Schmidt SD, Costa A, Rani B, Godfried Nachtigall E, Passani MB, Carta F, Nocentini A, de Carvalho Myskiw J, Furini CRG, Supuran CT, et al. The role of carbonic anhydrases in extinction of contextual fear memory. Proc Natl Acad Sci USA. 2020;117(27):16000–16008.
   PubMed Web of Science ®Google Scholar
• Wang X, Schröder HC, Schlossmacher U, Neufurth M, Feng Q, Diehl-Seifert B, Müller WEG. Modulation of the initial mineralization process of SaOS-2 cells by carbonic anhydrase activators and polyphosphate. Calcif Tissue Int. 2014;94(5):495–509.
   PubMed Web of Science ®Google Scholar
• Sun MK, Alkon DL. Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther. 2001;297(3):961–967.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase activators. Future Med Chem. 2018;10(5):561–573.
   PubMed Web of Science ®Google Scholar
• Elder I, Tu C, Ming L-J, McKenna R, Silverman DN. Proton transfer from exogenous donors in catalysis by human carbonic anhydrase II. Arch Biochem Biophys. 2005;437(1):106–114.
   PubMed Web of Science ®Google Scholar
• Angeli A, Berrino E, Carradori S, Supuran CT, Cirri M, Carta F, Costantino G. Amine- and amino acid-based compounds as carbonic anhydrase activators. Molecules. 2021;26(23):7331.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry. 2006;12(27):7057–7066.
   PubMed Web of Science ®Google Scholar
• Provensi G, Nocentini A, Passani MB, Blandina P, Supuran CT. Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives. J Enzyme Inhib Med Chem. 2021;36(1):719–726.
   PubMed Web of Science ®Google Scholar
• Tanini D, Capperucci A, Supuran CT, Angeli A. Sulfur, selenium and tellurium containing amines act as effective carbonic anhydrase activators. Bioorg Chem. 2019; 87(87516):516–522.
   PubMedGoogle Scholar
• Nocentini A, Cuffaro D, Ciccone L, Orlandini E, Nencetti S, Nuti E, Rossello A, Supuran CT. Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators. J Enzyme Inhib Med Chem. 2021;36(1):48–57.
   PubMed Web of Science ®Google Scholar
• Maccallini C, Di Matteo M, Vullo D, Ammazzalorso A, Carradori S, De Filippis B, Fantacuzzi M, Giampietro L, Pandolfi A, Supuran CT, et al. Indazole, pyrazole, and oxazole derivatives targeting nitric oxide synthases and carbonic anhydrases. ChemMedChem. 2016;11(16):1695–1699.
   PubMed Web of Science ®Google Scholar
• Sugimoto A, Ikeda H, Tsukamoto H, Kihira K, Ishioka M, Hirose J, Hata T, Fujioka H, Ono Y. Timolol activates the enzyme activities of human carbonic anhydrase I and II. Biol Pharm Bull. 2010;33(2):301–306.
   PubMed Web of Science ®Google Scholar
• Balsamo A, Breschi M, Chini M, Domiano P, Giannaccini G, Lucacchini A, Macchia B, Macchia M, Manera C, Martinelli A, et al. Conformationally restrained β-blocking oxime ethers: synthesis and β-adrenergic properties of diastereoisomeric anti and syn 2-(5′-isoxazolidinyl)-ethanolamines. Eur J Med Chem. 1992;27(8):751–764.
   Web of Science ®Google Scholar
• Balsamo A, Breschi M, Chiellini G, Lucacchini A, Macchia M, Martinelli A, Martini C, Nardini C, Orlandini E, Romagnoli F, et al. Conformationally restrained β-blocking oxime ethers. 2. Synthesis and β-adrenergic properties of diastereoisomeric anti and syn 2-(5′-(3′-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines. Eur J Med Chem . 1994;29(11):855–867.
   Web of Science ®Google Scholar
• Breschi M, Macchia M, Manera C, Micali E, Nardini C, Nencetti S, Rossello A, Scatizzi R. Conformationally restrained β-blocking oxime ethers. 3. Synthesis and β-adrenergic antagonistic activity of diastereomeric anti and syn 2-(5′-(3′-methyl)isoxazolidinyl)-N-alkylethanolamines. Eur J Med Chem. 1996;31(2):159–163.
   Web of Science ®Google Scholar
• Ramos BP, Colgan L, Nou E, Ovadia S, Wilson SR, Arnsten AFT. The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biol Psychiatry. 2005;58(11):894–900.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem. 1971;246(8):2561–2573.
   PubMed Web of Science ®Google Scholar
• Liu X, Lu D, Bowser R, Liu J. Expression of carbonic anhydrase i in motor neurons and alterations in ALS. IJMS. 2016;17(11):1820.
   Google Scholar
• Halmi P, Parkkila S, Honkaniemi J. Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int. 2006;48(1):24–30.
   PubMed Web of Science ®Google Scholar
• Svichar N, Waheed A, Sly WS, Hennings JC, Hübner CA, Chesler M. Carbonic anhydrases CA4 and CA14 both enhance AE3-mediated Cl–HCO3- exchange in hippocampal neurons. J Neurosci. 2009;29(10):3252–3258.
   PubMed Web of Science ®Google Scholar
• Ruusuvuori E, Kaila K. Carbonic anhydrases and brain pH in the control of neuronal excitability. Subcell Biochem. 2014;75:75271–75290.
   Google Scholar